Fibrobiologics Inc (FBLG)

Apr 07, 2025

Zacks Small Cap Weighs in on FibroBiologics Q1 Earnings - Defense World

Apr 07, 2025

Apr 04, 2025

FY2025 EPS Estimates for FibroBiologics Increased by Analyst - Defense World

Apr 04, 2025

Apr 03, 2025

FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25… - Zacks Small Cap Research

Apr 03, 2025

Apr 03, 2025

HC Wainwright Comments on FibroBiologics Q1 Earnings - Defense World

Apr 03, 2025

Apr 02, 2025

FibroBiologics gibt wissenschaftlicher Fortschritte bei der Reparatur von Hirngewebe bekannt - GlobeNewswire Inc.

Apr 02, 2025

Apr 02, 2025

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair - GlobeNewswire

Apr 02, 2025

Apr 02, 2025

FibroBiologics announces advancement in results of brain tissue repair - TipRanks

Apr 02, 2025

Apr 02, 2025

Fibrobiologics Announces Scientific Advancement In Confirmation Results Of Brain Tissue Repair - MarketScreener

Apr 02, 2025

Apr 02, 2025

Major Breakthrough: FibroBiologics Confirms Brain Tissue Regeneration Success - Stock Titan

Apr 02, 2025

Apr 02, 2025

FibroBiologics’ (FBLG) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Apr 02, 2025

Apr 02, 2025

Virtu Financial LLC Buys New Holdings in FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Apr 02, 2025

Apr 02, 2025

FibroBiologics’ (FBLG) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Apr 02, 2025

Mar 31, 2025

Fibrobiologics stock plunges to 52-week low at $0.93 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Fibrobiologics stock plunges to 52-week low at $0.93 amid market challenges - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

FibroBiologics Slashes Annual Losses by $5.3M as Key Clinical Trial Approaches - Stock Titan

Mar 31, 2025

Mar 28, 2025

Spotting Winners: TopBuild (NYSE:BLD) And Home Builders Stocks In Q4 - The Globe and Mail

Mar 28, 2025

Mar 27, 2025

FibroBiologics Announces 2025 Annual Meeting of Stockholders - GlobeNewswire

Mar 27, 2025

Mar 27, 2025

Biotech Pioneer FibroBiologics Reveals Massive 160+ Patent Portfolio at Upcoming Shareholder Meeting - Stock Titan

Mar 27, 2025

Mar 27, 2025

Applied Industrial (AIT): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail

Mar 27, 2025

Mar 26, 2025

3 Reasons to Avoid FUBO and 1 Stock to Buy Instead - The Globe and Mail

Mar 26, 2025

Mar 25, 2025

Intuitive Machines Stock (LUNR) Lifts Off with 30% Surge Post Q4 Results - The Globe and Mail

Mar 25, 2025

Mar 21, 2025

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - GlobeNewswire

Mar 21, 2025

Mar 21, 2025

FibroBiologics Announces Presentation on Innovative Fibroblast-Based Therapeutics at The German-Nordic Joint Extracellular Matrix Meeting - Nasdaq

Mar 21, 2025

Mar 21, 2025

FibroBiologics Reveals Groundbreaking Fibroblast Treatment Targeting 7 Major Diseases - Stock Titan

Mar 21, 2025

Mar 18, 2025

FBLG stock touches 52-week low at $0.98 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

FBLG stock touches 52-week low at $0.98 amid sharp annual decline - Investing.com Australia

Mar 18, 2025

Mar 12, 2025

Life Sciences Investor Forum Agenda Announced for March 13th - GlobeNewswire

Mar 12, 2025

Mar 04, 2025

FibroBiologics files patent application for fibroblast-based therapeutics - TipRanks

Mar 04, 2025

Mar 04, 2025

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics - GlobeNewswire

Mar 04, 2025

Mar 04, 2025

Could FibroBiologics' New Mitochondrial Therapy Patent Transform Treatment for Chronic Diseases? - StockTitan

Mar 04, 2025

Mar 02, 2025

FibroBiologics’ (FBLG) Buy Rating Reiterated at D. Boral Capital - Defense World

Mar 02, 2025

Feb 27, 2025

FibroBiologics and Charles River Announce Completion and - GlobeNewswire

Feb 27, 2025

Feb 27, 2025

FibroBiologics and Charles River complete master cell bank for clinical trials - TipRanks

Feb 27, 2025

Feb 27, 2025

FibroBiologics Completes Master Cell Bank for CYWC628 in Collaboration with Charles River Laboratories - Nasdaq

Feb 27, 2025

Feb 27, 2025

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic - GlobeNewswire

Feb 27, 2025

Feb 27, 2025

Can This New Cell Therapy Breakthrough Finally Solve the Diabetic Foot Ulcer Crisis? - Stock Titan

Feb 27, 2025

Feb 27, 2025

FibroBiologics (FBLG) Expected to Announce Earnings on Thursday - Defense World

Feb 27, 2025

Feb 24, 2025

Fibrobiologics stock plunges to 52-week low of $1.04 By Investing.com - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

Fibrobiologics stock plunges to 52-week low of $1.04 - Investing.com India

Feb 24, 2025

Feb 24, 2025

FBLG: Analyst Day Provides In-Depth Overview of Pipeline… - Zacks Small Cap Research

Feb 24, 2025

Feb 18, 2025

FibroBiologics' (FBLG) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Feb 18, 2025

Feb 16, 2025

FibroBiologics’ (FBLG) Buy Rating Reiterated at HC Wainwright - Armenian Reporter

Feb 16, 2025

Feb 15, 2025

Exploring Growth Opportunities In FibroBiologics Inc (NASDAQ: FBLG) - Stocks Register

Feb 15, 2025

Feb 15, 2025

D. Boral Capital Reaffirms “Buy” Rating for FibroBiologics (NASDAQ:FBLG) - Defense World

Feb 15, 2025

Feb 11, 2025

Should This Give FibroBiologics Inc (NASDAQ: FBLG) Investors Sleepless Nights? - Stocks Register

Feb 11, 2025

Feb 11, 2025

FibroBiologics Inc (FBLG) stock analysis: A comprehensive overview - US Post News

Feb 11, 2025